Medline Industries Recalls Nail Kits Due to Potential Sterility Concerns
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has issued a voluntary recall for 1,640 nail kits because the included sterile saline wound wash may not meet required sterility assurance levels.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Medline Industries, LP has initiated a voluntary recall of specific Medline Convenience Kits containing nail supplies. The recall was prompted by the discovery that the manufacturer of the sterile saline wound wash included in these kits may not have met the minimum required sterility assurance levels necessary for products labeled as sterile.
Which Products Are Affected
The recall affects the following product:
- Product Name: Medline Convenience Kits: NAIL KIT
- Model Number: POD14214
- Quantity: 1,640 units
- UDI-DI: 10889942819362 (each), 40889942819363 (case)
- Lot Numbers: 25CBS147, 25CBJ329, 25ABU209, 24DBJ364, 24DBB718, 23JBV524, 23IBU998, 23IBF119
Distribution of these kits was worldwide, including United States nationwide coverage and shipments to the Bahamas, Bermuda, and the Cayman Islands.
What You Should Do
Medline Industries notified affected customers via letter starting on January 5, 2026. Consumers and healthcare facilities should check their inventory for the model number POD14214 and the specific lot numbers listed above. If you possess any of the affected kits, you should follow the instructions provided in the firm's notification letter regarding the handling or return of the product.
Why This Matters
This recall is classified as Class II by the FDA. When a product labeled as sterile fails to meet sterility assurance levels, there is a potential risk of infection or other adverse health consequences for patients treated with the device.
Source
This information is based on official recall data provided by the FDA. Recall Number: Z-1432-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.